Cancer

Clinical Trial – Hyperbaric Oxygenation Treatment and Quality of Life

Osteoradionecrosis, dermal soft tissue necrosis, radiation cystitis, proctitis and sexual
dysfunctions are well-known late-effects after radiation for cancer in the pelvic area,
negatively affecting the survivors’ quality of life (QOL) and psychosocial wellbeing.
Increasing evidence and clinical practice support the use of hyperbaric oxygen treatment
(HBOT) as an effective treatment in a variety of radiation injuries, but this is still a
field with limited research and knowledge. Especially, there is a knowledge gap on how late
radiation tissue injury (LRTI) influences cancer survivors’ QOL and psychosocial health in a
longitudinal perspective (before, along and after HBOT), as well as the patients’ knowledge,
expectation and experience from this treatment. This study aims to improve knowledge on these
issues.

Laser and light therapy for treatment of radiation dermatitis.

Abstract: Radiation dermatitis (RD), an inflammatory skin disease that can be an unwanted side effect of medical radiation therapy (RT), most commonly occurs in patients undergoing cancer of the ENT, anal, and vulvar regions. The side effects on the skin and mucous...

Clinical Trial – Effects of Hyperbaric Oxygen (HBO) on Blood Count Recovery After Autologous Hematopoietic Stem Cell (HSPC) Transplant for Multiple Myeloma

Patients with Multiple Myeloma who are considered for high-dose therapy and autologous
transplantation at the bone marrow transplant clinic at the Wilmot Cancer Institute (WCI)
will be be approached to participate in this trial. Eligible patients who choose to
participate will be randomized so that half receive one hyperbaric oxygen therapy session
prior to hematopoetic stem cell infusion and half will not. All subjects will have their
blood counts monitored closely and time to count recovery will be compared between the two
groups.

Archives

Categories